Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
potential therapeutic targets and biomarkers. An ambitious technological development in the team focuses on single cell proteomics analysis to access tumor heterogeneity in patient-derived organoids and
-
cell culture, including organoid and spheroid production and cryopreservation; Cell viability testing; Transwell cell culture experiment; Synthesis, functionalization, and characterization of lipid and
-
and in vivo approaches. Your project will be focused on applying molecular biology, cell culture and analysis of brain development to uncover critical gene expression pathways regulated by this RNA
-
SPI/I2C Implementation of data transmission via a short-range wireless communication protocol, possibly Bluetooth Development of software for a cell phone or PC for display of the acquired and
-
for cellular therapy delivery, and 50% supporting the operational activities of the Institute of Transplantation Human Tissue Biobank. You will play a central role in delivering an MRC IAA-CiC–funded programme
-
Application deadline and submission: The call for applications is open from 20/02/2026 to 06/03/2026 the date of publication on the Euraxess portal. Applications must be sent by email to info@i3bs.uminho.pt
-
life science environment, and have backgrounds in any of the following fields: cell or developmental biology, immunology, neurobiology, biophysics, theoretical physics, computer science, bioinformatics
-
of the leading biomedical research institutions in the fields of neuroscience, metabolism and cardiovascular physiology in the Czech Republic. Using molecular, cellular and animal models, we tackle basic
-
of CTCs on a single cell level. Your role will require knowledge and laboratory skills in the field of cancer biology and next generation sequencing (NGS). You will join a wide community of technical staff
-
gaps in our understanding of disease biology and treatment response in Black men. Our project aims to close these gaps by developing cutting-edge induced pluripotent stem cell (iPSC) models that better